Related Experiment Video

Updated: Jan 1, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

2.7K

Dysfunctional miRNA-Mediated Regulation in Chromophobe Renal Cell Carcinoma

Xiaohan Sun1,2, Junying Zhang1

  • 1School of Computer Science and Technology, Xidian University, Xi'an, Shaanxi, P. R. China.

Plos One
|June 4, 2016
PubMed

Insights

This study introduces a new method to identify disease causes by analyzing microRNA (miRNA)-mediated gene regulation modules. It reveals that altered miRNA regulation, not just gene expression, underlies complex diseases like cancer.

Area of Science:

  • Bioinformatics
  • Molecular Biology
  • Genomics

Background:

  • Complex diseases may stem from microRNA (miRNA)-mediated gene regulation, beyond differential gene expression.
  • Identifying these regulatory changes is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To define and identify dysfunctional miRNA-mediated regulation modules as potential causes of complex diseases.
  • To develop a computational approach for assessing miRNA-mediated regulation changes.

Main Methods:

  • Defined miRNA-mediated regulation modules using Gene Ontology (GO) terms and miRNA-mRNA interactions.
  • Developed a single regulation-weight (SW) value to quantify miRNA-mediated regulation changes.
  • Applied the method to Chromophobe renal cell carcinoma data.

Main Results:

  • Identified 70 dysfunctional miRNA-mediated regulation modules from 4381 initial modules in Chromophobe renal cell carcinoma.
  • The identified modules comprehensively reflect the disease's characteristics.
  • The approach identified differentially miRNA-mediated regulated mRNAs, offering deeper disease associations than differentially expressed mRNAs.

Conclusions:

  • Accumulated alterations in miRNA-mediated regulation can lead to functional changes and disease development.
  • This method provides a novel framework for uncovering disease mechanisms.
  • The approach can identify key mRNAs with significant miRNA-mediated regulation relevant to disease.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

8.0K
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

15.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K